Recursion

Recursion – Technical Overview

Recursion is a US-based (Salt Lake City) clinical-stage TechBio company built around Recursion OS, an integrated AI-driven drug discovery platform. The system couples large-scale wet-lab automation with dry-lab machine learning pipelines to industrialize the early stages of drug discovery.

Key architectural and technical highlights:

• Recursion OS: A unified operating system for drug discovery that integrates biological experimentation, data generation, and AI/ML model inference into a single closed-loop pipeline.
• Experimental throughput: Up to 2 million experiments per week, enabled by highly automated laboratory infrastructure.
• Proprietary dataset: Over 50 petabytes of biological and chemical data, one of the largest purpose-built datasets in the industry, used to train and refine predictive models.
• Integrated wet/dry lab automation: Seamless coupling between physical laboratory robotics and computational analysis layers, enabling rapid hypothesis generation and validation cycles.
• Generative de novo chemistry: AI models capable of generating novel chemical structures, not merely screening existing compound libraries.
• Compound efficiency: Recursion's approach requires approximately 90% fewer compounds than the industry average to advance a program, reflecting high-precision target identification and lead optimization.
• Pipeline focus: Oncology and rare disease therapeutic areas, with programs progressing through clinical stages.